Evidence map›Paper›PMID 39222071›Full record

ArticleJournal of medical microbiology2024

Lessons learned: drive-through COVID-19 clinic testing during an adaptive epidemic response and a point-of-care test assessment of a computer-read rapid lateral flow immunoassay with fluorescence-based detection.

Leah Rankine-Wilson, Teresa Oncken, Irshan Basrewan, Courtney Jeffery, Todd M Pryce, Rebecca Wake, Aus A L Molan, T F Paton, Tim J J Inglis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Leah Rankine-WilsonDepartment of Clinical Microbiology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Murdoch, Australia.
Teresa OnckenDepartment of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Australia.
Irshan BasrewanDepartment of Clinical Microbiology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Murdoch, Australia.
Courtney JefferyDepartment of Clinical Microbiology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Murdoch, Australia.
Todd M PryceDepartment of Clinical Microbiology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Murdoch, Australia.
Rebecca WakePathWest Corporate, PathWest Laboratory Medicine WA, Nedlands, Australia.
Aus A L MolanPathWest Corporate, PathWest Laboratory Medicine WA, Nedlands, Australia.
T F PatonDepartment of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Australia.
Tim J J InglisDepartment of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Point-of-Care TestingSARS-CoV-2Sensitivity and SpecificityAntigens, ViralCOVID-19 Serological TestingCOVID-19 TestingFluorescenceHumansImmunoassayPoint-of-Care SystemsWestern AustraliaAntigens, Viralborder restrictionconformity studyCOVID-19drive-through clinicemergency responsePCRrapid antigen testSARS-CoV-2trialWestern Australia

Identifiers

PMID39222071
PMCPMC12455235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.